Defence Therapeutics, Inc. engages in the research and development of anti-body drug conjugates. It focuses on enhancing intracellular delivery of biological or biosimilar therapeutic drugs targeting cancer and infectious diseases. The company was founded by Simon Beaudoin and Sébastien Plouffe on July 18, 2017 and is headquartered in Vancouver, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Defence Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Defence Therapeutics Inc market cap is $40.5M.
What is the 52-week high for Defence Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Defence Therapeutics Inc 52 week high is $1.66 as of September 07, 2025.
What is the 52-week low for Defence Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Defence Therapeutics Inc 52 week low is $0.48 as of September 07, 2025.
What is Defence Therapeutics Inc stock price today?
Defence Therapeutics Inc stock price today is $0.74.
What was Defence Therapeutics Inc stock price yesterday?
Defence Therapeutics Inc stock price yesterday was $0.70.
What is the PE ratio of Defence Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Defence Therapeutics Inc’s P/E ratio is -9.28.
What is the Price-to-Book ratio of Defence Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Defence Therapeutics Inc P/B ratio is -184.0796.
What is the 50-day moving average of Defence Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Defence Therapeutics Inc 50-day moving average is $0.661.